Semin Thromb Hemost
DOI: 10.1055/s-0044-1796630
Review Article

Regulatory Effect of PDGF/PDGFR on Hematopoiesis

Yong Liu*
1   Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China
2   Pediatric Hematology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China
,
Junbin Huang*
2   Pediatric Hematology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China
,
Lindi Li*
2   Pediatric Hematology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China
,
Yifei Duan
2   Pediatric Hematology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China
,
Beng H. Chong
3   Haematology Research Unit, School of Clinical Medicine, St George and Sutherland Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia
4   New South Wales Health Pathology, St George Hospital, Kogarah, New South Wales, Australia
,
Liang Li
2   Pediatric Hematology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China
,
Mo Yang
1   Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China
2   Pediatric Hematology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China
5   Department of Hematology, Affiliated Hospital of Guangdong Medical University (GDMU), Zhanjiang, Guangdong, China
› Author Affiliations
Funding This research was supported by the Shenzhen Science and Technology Innovation Commission Fund (JCYJ20230807110419041 to M.Y.).

Abstract

Platelet-derived growth factor (PDGF) is a critical cytokine with substantial regulatory effects on hematopoiesis. Recent research highlights the essential role of PDGF in the modulation of hematopoietic stem/progenitor cells (HSPCs), megakaryocytes/platelets, and thrombopoietin (TPO) synthesis within the bone marrow microenvironment. PDGF directly stimulates the proliferation and differentiation of HSPCs while also inhibiting apoptosis. In addition, PDGF indirectly enhances the production of other growth factors, including granulocyte–macrophage colony-stimulating factors. Further, PDGF regulates TPO production and influences the bone marrow milieu, thus impacting hematopoiesis and platelet formation. Mechanistically, PDGF binds to its receptor, PDGF receptor (PDGFR), thus activating the PDGF/PDGFR signaling pathway. This pathway subsequently activates phosphoinositide 3-kinase/protein kinase B, leading to the activation of downstream cytokines, including c-Fos and NF-E2, while inhibiting caspase-3 activation. Collectively, these actions have prodifferentiation and antiapoptotic effects on megakaryocytes, thereby regulating platelet production. This review provides a comprehensive analysis of the regulatory role of the PDGF/PDGFR axis in hematopoiesis, with a particular focus on platelet production, by summarizing all studies on PDGF/PDGFR from our group and globally.

Authors' Contributions

Y.L., J.H., L.L., and Y.D. wrote the manuscript. B.H.C., Liang Li, and M.Y. reviewed, edited, and revised the manuscript. All authors read and approved the final article.


* These authors contributed equally to this article.




Publication History

Article published online:
28 November 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Zou X, Tang XY, Qu ZY. et al. Targeting the PDGF/PDGFR signaling pathway for cancer therapy: a review. Int J Biol Macromol 2022; 202: 539-557
  • 2 Ye Q, Liu Y, Zhang G. et al. Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice. Nat Commun 2023; 14 (01) 1402
  • 3 Rogers MA, Campaña MB, Long R, Fantauzzo KA. PDGFR dimer-specific activation, trafficking and downstream signaling dynamics. J Cell Sci 2022; 135 (17) jcs259686
  • 4 Wang C, Ji J, Jin Y. et al. Tumor-mesothelium HOXA11-PDGF BB/TGF β1-miR-181a-5p-Egr1 feedforward amplifier circuity propels mesothelial fibrosis and peritoneal metastasis of gastric cancer. Oncogene 2024; 43 (03) 171-188
  • 5 Sang BT, Wang CD, Liu X, Guo JQ, Lai JY, Wu XM. PDGF-BB/PDGFRβ induces tumour angiogenesis via enhancing PKM2 mediated by the PI3K/AKT pathway in Wilms' tumour. Med Oncol 2023; 40 (08) 240
  • 6 Zuo T, Liu Y, Duan M. et al. Platelet-derived growth factor PDGF-AA upregulates connexin 43 expression and promotes gap junction formations in osteoblast cells through p-Akt signaling. Biochem Biophys Rep 2023; 34: 101462
  • 7 Cao Z, Liu Y, Wang Y, Leng P. Research progress on the role of PDGF/PDGFR in type 2 diabetes. Biomed Pharmacother 2023; 164: 114983
  • 8 Ntokou A, Dave JM, Kauffman AC. et al. Macrophage-derived PDGF-B induces muscularization in murine and human pulmonary hypertension. JCI Insight 2021; 6 (06) e139067
  • 9 Wang Y, Wang P, Yu Y. et al. Hepatocyte Ninjurin 2 promotes hepatic stellate cell activation and liver fibrosis through the IGF1R/EGR1/PDGF-BB signaling pathway. Metabolism 2023; 140: 155380
  • 10 Su RJ, Zhang XB, Li K. et al. Platelet-derived growth factor promotes ex vivo expansion of CD34+ cells from human cord blood and enhances long-term culture-initiating cells, non-obese diabetic/severe combined immunodeficient repopulating cells and formation of adherent cells. Br J Haematol 2002; 117 (03) 735-746
  • 11 Damm EW, Clements WK. Pdgf signalling guides neural crest contribution to the haematopoietic stem cell specification niche. Nat Cell Biol 2017; 19 (05) 457-467
  • 12 Mao A, Li Z, Ning G. et al. Sclerotome-derived PDGF signaling functions as a niche cue responsible for primitive erythropoiesis. Development 2023; 150 (22) dev201807
  • 13 Sá da Bandeira D, Kilpatrick AM, Marques M. et al. PDGFRβ+ cells play a dual role as hematopoietic precursors and niche cells during mouse ontogeny. Cell Rep 2022; 40 (03) 111114
  • 14 Su RJ, Li K, Zhang XB. et al. Platelet-derived growth factor enhances expansion of umbilical cord blood CD34+ cells in contact with hematopoietic stroma. Stem Cells Dev 2005; 14 (02) 223-230
  • 15 Kim DY, Park G, Hong HS, Kim S, Son Y. Platelet-derived growth factor-BB priming enhances vasculogenic capacity of bone marrow-derived endothelial precursor like cells. Tissue Eng Regen Med 2023; 20 (05) 695-704
  • 16 Tu W, Feng M, Zhou Q. et al. GATA2–miR–374a axis promotes vascular smooth muscle cells proliferation, migration via targeting circTADA2A/RORA axis. Exp Ther Med 2024; 28 (03) 357
  • 17 Huang W, Zhou H, He Y. et al. A novel PDGFR inhibitor WQ-C-401 prevents pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension. Exp Cell Res 2024; 441 (01) 114154
  • 18 Lim SE, Esain V, Kwan W. et al. HIF1α-induced PDGFRβ signaling promotes developmental HSC production via IL-6 activation. Exp Hematol 2017; 46: 83-95.e6
  • 19 Ramasz B, Krüger A, Reinhardt J. et al. Hematopoietic stem cell response to acute thrombocytopenia requires signaling through distinct receptor tyrosine kinases. Blood 2019; 134 (13) 1046-1058
  • 20 Kuang C, Xia M, An G. et al. Excessive serine from the bone marrow microenvironment impairs megakaryopoiesis and thrombopoiesis in multiple myeloma. Nat Commun 2023; 14 (01) 2093
  • 21 Yang M, Khachigian LM, Hicks C, Chesterman CN, Chong BH. Identification of PDGF receptors on human megakaryocytes and megakaryocytic cell lines. Thromb Haemost 1997; 78 (02) 892-896
  • 22 Yang M, Chesterman CN, Chong BH. Recombinant PDGF enhances megakaryocytopoiesis in vitro. Br J Haematol 1995; 91 (02) 285-289
  • 23 Mao LJ, Ye JY, Liang EY, Yang M. PDGF-BB promotes CFU-GM and CFU-MK formation and its possible mechanism [in Chinese]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2017; 25 (02) 555-561
  • 24 Yang J, Pan C, Pan Y. et al. A carbon 21 steroidal glycoside with pregnane skeleton from Cynanchum atratum bunge promotes megakaryocytic and erythroid differentiation in erythroleukemia HEL cells through regulating platelet-derived growth factor receptor beta and JAK2/STAT3 pathway. Pharmaceuticals (Basel) 2024; 17 (05) 628
  • 25 Su RJ, Li K, Yang M. et al. Platelet-derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood. Bone Marrow Transplant 2001; 27 (10) 1075-1080
  • 26 Xu S, Liu Y, Zhang D. et al. PDGF-AA promotes gap junction intercellular communication in chondrocytes via the PI3K/Akt pathway. Connect Tissue Res 2022; 63 (05) 544-558
  • 27 Okekawa A, Wada T, Onogi Y. et al. Platelet-derived growth factor signaling in pericytes promotes hypothalamic inflammation and obesity. Mol Med 2024; 30 (01) 21
  • 28 Singh A, Veeriah V, Xi P. et al. Angiocrine signals regulate quiescence and therapy resistance in bone metastasis. JCI Insight 2019; 4 (13) e125679
  • 29 Ye JY, Chan GC, Qiao L. et al. Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway. Haematologica 2010; 95 (10) 1745-1753
  • 30 Luo Y, Kong HM, Su WQ. et al. The hematopoietic protective effect of PDGF-BB on radiation-induced myelosuppression model mice [in Chinese]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2022; 30 (06) 1873-1880
  • 31 Zhou LX, Liang EY, Ye JY, Yang M. Role of PDGF/PDGFR pathway in essential thrombocythemia and its action mechanism [in Chinese]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2016; 24 (02) 526-530
  • 32 Kaminski WE, Lindahl P, Lin NL. et al. Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice. Blood 2001; 97 (07) 1990-1998
  • 33 Urs AP, Goda C, Kulkarni R. Remodeling of the bone marrow microenvironment during acute myeloid leukemia progression. Ann Transl Med 2024; 12 (04) 63
  • 34 Yang M, Li K, Lam AC. et al. Platelet-derived growth factor enhances granulopoiesis via bone marrow stromal cells. Int J Hematol 2001; 73 (03) 327-334
  • 35 Hosaka K, Wang C, Zhang S. et al. Perivascular localized cells commit erythropoiesis in PDGF-B-expressing solid tumors. Cancer Commun (Lond) 2023; 43 (06) 637-660
  • 36 Hitchcock IS, Hafer M, Sangkhae V, Tucker JA. The thrombopoietin receptor: revisiting the master regulator of platelet production. Platelets 2021; 32 (06) 770-778
  • 37 Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 1997; 89 (01) 101-107
  • 38 Sungaran R, Chisholm OT, Markovic B, Khachigian LM, Tanaka Y, Chong BH. The role of platelet alpha-granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells. Blood 2000; 95 (10) 3094-3101
  • 39 Ohsaka A, Hirota-Komatsu S, Araki M, Komatsu N. Platelet-derived growth factor receptors form complexes with neuropilin-1 during megakaryocytic differentiation of thrombopoietin-dependent UT-7/TPO cells. Biochem Biophys Res Commun 2015; 459 (03) 443-449
  • 40 Glaviano A, Foo ASC, Lam HY. et al. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer 2023; 22 (01) 138
  • 41 Shu LL, Yang M. Imatinib in treatment of thrombocythemia and other myeloproliferative diseases [in Chinese]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012; 20 (06) 1507-1512
  • 42 Lin CL, Tsai ML, Chen YH. et al. Platelet-derived growth factor receptor-α subunit targeting suppresses metastasis in advanced thyroid cancer in vitro and in vivo . Biomol Ther (Seoul) 2021; 29 (05) 551-561
  • 43 Park WH. Propyl gallate induces human pulmonary fibroblast cell death through the regulation of Bax and caspase-3. Ann Med 2024; 56 (01) 2319853
  • 44 Zhu P, Wang Z, Sun Z, Liao B, Cai Y. Recombinant platelet-derived growth factor-BB alleviates osteoarthritis in a rat model by decreasing chondrocyte apoptosis in vitro and in vivo. J Cell Mol Med 2021; 25 (15) 7472-7484
  • 45 Chui CM, Li K, Yang M. et al. Platelet-derived growth factor up-regulates the expression of transcription factors NF-E2, GATA-1 and c-Fos in megakaryocytic cell lines. Cytokine 2003; 21 (02) 51-64